Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of AKRO
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Akero Therapeutics Inc. stock price fell more than -5.53% Friday closing at $19.65
(Updated on May 10, 2024)

Sell candidate since May 10, 2024 PDF

The Akero Therapeutics Inc. stock price fell by -5.53% on the last day (Friday, 10th May 2024) from $20.80 to $19.65. It has now fallen 4 days in a row. During the last trading day the stock fluctuated 9.49% from a day low at $19.59 to a day high of $21.45. The price has fallen in 7 of the last 10 days and is down by -0.46% for this period. Volume has increased on the last day by 155 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 536 thousand shares were bought and sold for approximately $10.54 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -19.64% during the next 3 months and, with a 90% probability hold a price between $14.29 and $21.35 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

AKRO Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, April 25, 2024, and so far it has risen 3.80%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Akero Therapeutics Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $20.71 and $21.85. A break-up above any of these levels will issue buy signals. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Akero Therapeutics Inc. stock

Akero Therapeutics Inc. finds support from accumulated volume at $19.62 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.86 between high and low, or 9.49%. For the last week, the stock has had daily average volatility of 6.84%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (AKRO) For The Upcoming Trading Day Of Monday 13th

For the upcoming trading day on Monday, 13th we expect Akero Therapeutics Inc. to open at $20.23, and during the day (based on 14 day Average True Range), to move between $18.39 and $20.91, which gives a possible trading interval of +/-$1.26 (+/-6.39%) up or down from last closing price. If Akero Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 12.78% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $19.62 (0.15%) than the resistance at $20.59 (4.78%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Akero Therapeutics Inc. stock A Buy?

Akero Therapeutics Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Strong Sell candidate.

Current score: -5.065 Strong Sell Candidate Downgraded

Predicted Opening Price for Akero Therapeutics Inc. of Monday, May 13, 2024

Fair opening price May 13, 2024 Current price
$20.23 ( 2.95%) $19.65

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for AKRO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 22.09 12.42 %
R2 21.38 8.80 %
R1 20.94 6.57 %
Current price: 19.65
Support S1 19.52 -0.664 %
S2 19.08 -2.90 %
S3 18.37 -6.51 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 21.88 11.35 %
R2 21.75 10.69 %
R1 20.59 4.78 %
Current price 19.65
Support S1 19.62 -0.153%
S2 18.93 -3.66%
S3 0 .

FAQ

What is the symbol for Akero Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Akero Therapeutics Inc. is AKRO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Akero Therapeutics Inc. Stock?
Akero Therapeutics Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Strong Sell candidate.

How to buy Akero Therapeutics Inc. Stock?
Akero Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Akero Therapeutics Inc. Stock.

What's the current price of Akero Therapeutics Inc. Stock?
As of the end of day on the May 10, 2024, the price of an Akero Therapeutics Inc. (AKRO) share was $19.65.

What is the 52-week high and low for Akero Therapeutics Inc. Stock?
The 52-week high for Akero Therapeutics Inc. Stock is $58.38 and the 52-week low is $11.25.

What is the market capitalization of Akero Therapeutics Inc. Stock?
As of the May 10, 2024, the market capitalization of Akero Therapeutics Inc. is 1.434B.

When is the next earnings date for Akero Therapeutics Inc.?
The upcoming earnings date for Akero Therapeutics Inc. is May 20, 2024.
Click to get the best stock tips daily for free!

About Akero Therapeutics Inc.

Akero Therapeutics. Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regulates metabolism of lipids, carbohydrates, and proteins throughout the body. It also conducts a Phase 2a ... AKRO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT